ADGM
Adagio Medical·NASDAQ
--
--(--)
--
--(--)
ADGM fundamentals
During Q3 2025, Adagio Medical (ADGM) reported revenue of 0, a YoY change of -100.00%. Net income was -10.12M, a YoY change of -380.59%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | TTM |
|---|
Start Date | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 31, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | -- |
End Date | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 41.00K -- | 78.00K -- | 26.00K -- | 254.00K -- | 132.00K +221.95% | 137.00K +75.64% | -- -- | -- -- | 0 -100.00% | -- -- |
Sales and Services Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 465.00K -- | -- -- | 26.00K -- | 254.00K -- | 132.00K -71.61% | 137.00K -- | 0 -100.00% | 0 -100.00% | 0 -100.00% | 137.00K -- |
Cost of Revenue | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 253.00K -- | 334.00K -- | 542.00K -- | 682.00K -- | 414.00K +63.64% | 1.52M +355.99% | 253.00K -53.32% | 342.00K -49.85% | 31.00K -92.51% | 2.15M -- |
Cost of Goods and Services | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 1.79M -- | -- -- | 542.00K -- | 682.00K -- | 414.00K -76.94% | 1.52M -- | 253.00K -53.32% | 342.00K -49.85% | 31.00K -92.51% | 2.15M -- |
Gross Profit | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.33M -- | -- -- | -516.00K -- | -428.00K -- | -282.00K +78.80% | -1.39M -- | -253.00K +50.97% | -342.00K +20.09% | -31.00K +89.01% | -2.01M -- |
Operating Expenses | 5.43K -- | 225.58K -- | 166.91K -- | 5.11M -- | 1.12M +20460.44% | 252.72K +12.03% | 304.81K +82.62% | 180.41K -96.47% | 271.14K -75.70% | 968.60K +283.27% | 78.85K -74.13% | 24.77M +13632.99% | -- -- | 8.30M +756.81% | 6.23M +7802.25% | 4.14M -83.28% | 56.67M -- | 7.14M -13.92% | 4.38M -29.79% | 5.69M +37.34% | 73.88M -- |
Selling, General and Administrative Expenses | 5.43K -- | 225.58K -- | 166.91K -- | 5.11M -- | 1.12M +20460.44% | 252.72K +12.03% | 304.81K +82.62% | 180.41K -96.47% | 271.14K -75.70% | 968.60K +283.27% | 78.85K -74.13% | 15.97M +8753.97% | -- -- | 4.83M +398.66% | 3.37M +4168.81% | 2.93M -81.68% | 4.05M -- | 3.48M -27.85% | 2.40M -28.58% | 2.92M -0.34% | 12.86M -- |
General and Administrative Expenses | 13.54K -- | -- -- | -- -- | -- -- | 6.61M +48753.00% | -- -- | -- -- | -- -- | 1.01M -84.74% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Research and Development Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 8.80M -- | -- -- | 3.47M -- | 2.87M -- | 1.22M -86.17% | 3.42M -- | 3.66M +5.48% | 1.97M -31.20% | 2.77M +127.94% | 11.82M -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 49.20M -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -5.43K -- | -225.58K -- | -166.91K -- | -5.11M -- | -1.12M -20460.44% | -252.72K -12.03% | -304.81K -82.62% | -180.41K +96.47% | -271.14K +75.70% | -968.60K -283.27% | -78.85K +74.13% | -26.11M -14370.22% | -- -- | -8.81M -810.08% | -6.66M -8345.04% | -4.42M +83.05% | -58.05M -- | -7.40M +16.09% | -4.72M +29.16% | -5.72M -29.29% | -75.89M -- |
Non-Operating Income (Loss) | 0 -- | 15.33K -- | 4.49K -- | 12.52K -- | 20.00K -- | 41.54K +171.02% | 108.81K +2326.02% | 745.23K +5850.87% | 1.18M +5804.35% | 1.13M +2617.75% | 460.36K +323.10% | 8.43M +1031.60% | -- -- | 797.00K -29.40% | 925.00K +100.93% | 8.03M -4.77% | 686.00K -- | -316.00K -139.65% | 770.00K -16.76% | -4.40M -154.75% | -3.26M -- |
Gain (Loss) on Change in Fair Value | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 10.48M -- | -- -- | 1.59M -- | 1.68M -- | 8.23M -21.47% | -723.00K -- | 228.00K -85.69% | 1.29M -23.36% | -3.74M -145.44% | -2.95M -- |
Other Non-Operating Income (Loss) | -- -- | 15.33K -- | 4.49K -- | 12.52K -- | -32.33K -- | -- -- | -- -- | 745.23K +5850.87% | -895.57K -2669.75% | -- -- | -- -- | 39.00K -94.77% | -- -- | -43.00K -- | 5.00K -- | 72.00K +84.62% | 1.82M -- | -46.00K -6.98% | 102.00K +1940.00% | 12.00K -83.33% | 1.89M -- |
Net Interest Expense | -- -- | -- -- | -- -- | -- -- | -52.34K -- | -41.54K -- | -108.81K -- | -- -- | -2.08M -3867.74% | -1.13M -2617.75% | -460.36K -323.10% | 2.08M -- | -- -- | 753.00K +166.71% | 758.00K +264.65% | 269.00K -87.09% | 416.00K -- | 498.00K -33.86% | 618.00K -18.47% | 670.00K +149.07% | 2.20M -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 2.25M -- | -- -- | 754.00K -- | 760.00K -- | 435.00K -80.69% | 670.00K -- | 662.00K -12.20% | 720.00K -5.26% | 749.00K +72.18% | 2.80M -- |
Interest Income | -- -- | -- -- | -- -- | -- -- | 52.34K -- | 41.54K -- | 108.81K -- | -- -- | 2.08M +3867.74% | 1.13M +2617.75% | 460.36K +323.10% | 169.00K -- | -- -- | 1.00K -99.91% | 2.00K -99.57% | 166.00K -1.78% | 254.00K -- | 164.00K +16300.00% | 102.00K +5000.00% | 79.00K -52.41% | 599.00K -- |
Pretax Income From Continuing Operations | -5.43K -- | -210.25K -- | -162.43K -- | -5.09M -- | -1.10M -20091.87% | -211.19K -0.44% | -196.00K -20.67% | 564.82K +111.09% | 909.85K +183.03% | 160.25K +175.88% | 381.51K +294.65% | -10.76M -2005.20% | -8.62M -1047.52% | -8.02M -5103.46% | -5.73M -1602.96% | 3.61M +133.51% | -57.37M -565.46% | -7.71M +3.80% | -3.95M +31.16% | -10.12M -380.59% | -79.15M -- |
Income Tax Expense | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -5.43K -- | -210.25K -- | -162.43K -- | -5.09M -- | -1.10M -20091.87% | -211.19K -0.44% | -196.00K -20.67% | 564.82K +111.09% | 909.85K +183.03% | 160.25K +175.88% | 381.51K +294.65% | -10.76M -2005.20% | -8.62M -1047.52% | -8.02M -5103.46% | -5.73M -1602.96% | 3.61M +133.51% | -57.37M -565.46% | -7.71M +3.80% | -3.95M +31.16% | -10.12M -380.59% | -79.15M -- |
Net Income Attributable to Owners of the Company | -5.43K -- | -210.25K -- | -162.43K -- | -5.09M -- | -1.10M -20091.87% | -211.19K -0.44% | -196.00K -20.67% | 564.82K +111.09% | 909.85K +183.03% | 160.25K +175.88% | 381.51K +294.65% | -17.67M -3228.77% | -- -- | -8.02M -5103.46% | -5.73M -1602.96% | 3.61M +120.41% | -57.37M -- | -7.71M +3.80% | -3.95M +31.16% | -10.12M -380.59% | -79.15M -- |
Net Income Attributable to Common Stockholders | -5.43K -- | -210.25K -- | -162.43K -- | -5.09M -- | -1.10M -20091.87% | -211.19K -0.44% | -196.00K -20.67% | 564.82K +111.09% | 909.85K +183.03% | 160.25K +175.88% | 381.51K +294.65% | -17.67M -3228.77% | -- -- | -8.02M -5103.46% | -5.73M -1602.96% | 3.61M +120.41% | -57.37M -- | -7.71M +3.80% | -3.95M +31.16% | -10.12M -380.59% | -79.15M -- |
Other Comprehensive Income | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 4.00K -- | -10.00K -- | 3.00K -- | 2.00K -- | -9.00K -325.00% | 10.00K +200.00% | -61.00K -2133.33% | -39.00K -2050.00% | 4.00K +144.44% | -86.00K -- |
Total Comprehensive Income | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -10.76M -- | -8.63M -- | -8.02M -- | -5.73M -- | 3.60M +133.44% | -57.36M -564.57% | -7.77M +3.01% | -3.99M +30.46% | -10.11M -381.18% | -79.23M -- |
Total Comprehensive Income Attributable to Owners of the Company | -13.54K -- | -- -- | -- -- | -- -- | -6.56M -48366.45% | -- -- | -- -- | -- -- | 1.07M +116.27% | -- -- | -- -- | -17.68M -- | -- -- | -8.02M -- | -5.73M -- | 3.60M +120.35% | -57.36M -- | -7.77M +3.01% | -3.99M +30.46% | -10.11M -381.18% | -79.23M -- |
Basic EPS | -- -- | -0.02 -- | -0.01 -- | -0.27 -- | -0.06 -- | -0.01 +50.00% | -0.01 -- | 0.03 +111.11% | 0.05 +183.33% | 0.01 +200.00% | 0.05 +600.00% | -14.15 -47266.67% | -1.09 -2280.00% | -10.28 -102900.00% | -7.35 -14800.00% | 0.18 +101.27% | -3.77 -245.87% | -0.5 +95.14% | -0.26 +96.46% | -0.66 -466.67% | -5.19 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -25.9 -- | -- -- | -10.28 -- | -7.35 -- | 0.18 +100.69% | -- -- | -0.5 +95.14% | -0.26 +96.46% | -0.66 -466.67% | -- -- |
Diluted EPS | -- -- | -0.02 -- | -0.01 -- | -0.27 -- | -- -- | -0.01 +50.00% | -0.01 -- | 0.03 +111.11% | -- -- | 0.01 +200.00% | 0.05 +600.00% | -14.15 -47266.67% | -- -- | -10.28 -102900.00% | -7.35 -14800.00% | 0.02 +100.14% | -- -- | -0.51 +95.04% | -0.35 +95.24% | -0.66 -3400.00% | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -26.06 -- | -- -- | -10.28 -- | -7.35 -- | 0.02 +100.08% | -- -- | -0.51 +95.04% | -0.35 +95.24% | -0.66 -3400.00% | -- -- |
You can ask Aime
What were the key takeaways from Adagio Medical's earnings call?What is Adagio Medical's latest dividend and current dividend yield?What guidance did Adagio Medical's management provide for the next earnings period?What does Adagio Medical do and what are its main business segments?What is Adagio Medical's gross profit margin?What is the revenue and EPS growth rate for Adagio Medical year over year?What were the key takeaways from Adagio Medical’s earnings call?Did Adagio Medical beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
